ARI Sodium Iodide (131I) 20,000MBq/mL oral solution
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
01-12-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
sodium iodide(131I), Quantity: 20000 MBq/mL
Available from:
Australian Nuclear Science and Technology Organisation T/A ANSTO
INN (International Name):
Sodium iodide(131I)
Pharmaceutical form:
Oral Liquid, solution
Composition:
Excipient Ingredients: sodium bicarbonate; sodium thiosulfate pentahydrate; water for injections
Administration route:
Oral
Units in package:
3 x 10mL vial
Prescription type:
Not scheduled. Not considered by committee
Therapeutic indications:
Sodium Iodide (131I) solution is indicated in the treatment of hypesthysoidism and the detection and abletion of residual functioning thyroid tissue in differentiated throid calcinoma.
Product summary:
Visual Identification: Clear colourless solution.; Container Type: Vial; Container Life Time: 14 Days
Authorization status:
Licence status A
Authorization date:
1996-06-12
